TITLE

The Use of the American Society of Anesthesiology Classification as a Prognostic Factor in Patients with Renal Cell Carcinoma

AUTHOR(S)
Zequi, Stênio de Cássio; de Campos, Eurico C. R.; Guimarães, Gustavo C.; Bachega Jr., Wilson; da Fonseca, Francisco P.; Lopes, Ademar
PUB. DATE
February 2010
SOURCE
Urologia Internationalis;Feb2010, Vol. 84 Issue 1, p67
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: We analyzed whether the American Society of Anesthesiology (ASA) classification could be used as a prognostic factor in renal cell carcinoma. Methods: ASA classification’s impact on cancer-specific survival (CSS) and on overall survival in 145 patients submitted to radical or partial nephrectomy was evaluated, and was compared with clinicopathological variables. Results: CSS was influenced by ASA in uni- and multivariate analyses. Five-year CSS was 95.7, 71.1 and 39.8% for ASA 1, ASA 2 and ASA 3, respectively (p = 0.007). The ASA classification influenced the overall survival too (p < 0.001). When 18 patients with metastases were excluded, the CSS was 95.7, 83.9 and 42.9% for ASA 1, ASA 2 and ASA 3, respectively (p = 0.001). ASA 3 patients had ten times more metastases than ASA1 patients and two times more than ASA 2 patients (p = 0.001). ASA 3 patients had fewer incidental tumors (p = 0.043) than ASA 2 and 3 patients. Conclusion: In this series, the ASA classification could be used as a prognostic factor in renal cell carcinoma. Copyright © 2010 S. Karger AG, Basel
ACCESSION #
48171165

 

Related Articles

  • New Cut-Off Point between T1 and T2 Renal Cell Carcinoma – Necessary for a Better Discriminatory Power of the TNM Classification. Wunderlich, H.; Dreihaupt, M.; Schlichter, A.; Kosmehl, H.; Reichelt, O.; Schubert, J. // Urologia Internationalis;Feb2004, Vol. 72 Issue 2, p123 

    Purpose: We evaluated the pathological features of tumor size, lymph node and distant metastases, cell type, growth pattern, infiltration pattern, histological grade, local invasion and venous involvement of organ-confined renal carcinomas. The aim of this study was the re-evaluation of the TNM...

  • RENAL CELL CARCINOMA. Frank, Igor; Blute, Michael L. // Contemporary Urology;Aug2006, Vol. 18 Issue 8, p42 

    The article the use of tumor, node and metastasis staging as predictor of survival in patients with renal cell carcinoma. Clinical information on renal cell carcinoma is presented. A comparison between staging and prognostic models is provided. An outlook for cancer staging and outcome...

  • Mini-Margin Nephron Sparing Surgery for Renal Cell Carcinoma 4 cm or Less. Quanlin Li; Hongwei Guan; Jie Qin; Tao Jiang // Advances in Urology;2010, p1 

    Objectives. To explore the safety and efficacy of mini-margin nephron sparing surgery (NSS) for renal cell carcinoma (RCC) 4 cm or less. Methods. Total of 389 cases of RCC 4 cm or less with normal contralateral kidneys were included in the study, including 135 cases treated by mini-margin NSS,...

  • Renal Cell Carcinoma: The Experience of Kuwait Cancer Control Center, Kuwait. Z.S. Thotathil; A. Varghese; A. Ragheb // Medical Principles & Practice;Jan/Feb2005, Vol. 14 Issue 1, p1 

    Objectives: This retrospective study was undertaken to analyze the profile of patients presenting with renal cell carcinoma (RCC) and treatment outcomes. Subjects and Methods: Records of 49 patients (36 male, 16 female, 21–75 years) treated at the Kuwait Cancer Control Center, Kuwait for RCC...

  • Renal Cell Carcinoma in Two Patients with Crossed Fused Ectopic Kidneys. Davis, Carley M.; Rao, Manoj V.; Flanigan, Robert C.; Quek, Marcus L. // Urologia Internationalis;Oct2008, Vol. 81 Issue 3, p370 

    Primary renal malignancies involving crossed fused ectopic kidneys have rarely been reported. We describe two cases of renal cell carcinoma involving the orthotopic renal moiety in one patient and the heterotopic crossed renal moiety in another patient. Both patients were treated with surgical...

  • PET Scans for Decision-Making in Metastatic Renal Cell Carcinoma: A Single-Institution Evaluation. Dilhuydy; Durieux; Pariente; de Clermont; Pasticier; Monteil; Ravaud // Oncology;2006, Vol. 70 Issue 5, p339 

    Objective: Therapeutic decision-making in metastatic renal cell carcinoma (MRCC) is based on conventional radiological evaluation. Fluorodeoxyglucose positron emission tomography (FDG-PET) scans may modify this strategy. Methods: Patients with MRCC for whom a therapeutic decision had been made...

  • Behandlungsstrategien bei Skelettmetastasen. Leithner, A.; Friesenbichler, J.; Andreou, D.; Maurer-Ertl, W.; Tunn, P.U. // Der Orthopäde;Oct2012, Vol. 41 Issue 10, p863 

    The primary goals of multimodal, interdisciplinary treatment of bone metastases are to achieve mobility, pain relief, and improve quality of life. In cooperation with radiotherapists and oncologists, an individual therapy plan has to be designed. As bone metastases are a sign of a systemic...

  • Primary clear cell meningioma of the orbit mimicking a metastatic carcinoma: usefulness of immunohistochemistry and cytogenetic analysis. Maxime Benchetritt; Véronique Hofman; Elodie Long; Guillaume Odin; Elodie Basc; Basile Pasquier; Florence Pedeutour // Virchows Archiv;Feb2008, Vol. 452 Issue 2, p209 

    Abstract  Clear cell meningiomas (CCM) are rare tumors of the nervous system that usually occur in young patients and display high recurrence rates and potentially aggressive behavior. In this report, we describe a primary CCM of the orbit in an 84-year-old man with a previous...

  • Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies. Janice Dutcher; Paul de Souza; David McDermott; Robert Figlin; Anna Berkenblit; Alexandra Thiele; Mizue Krygowski; Andrew Strahs; Jay Feingold; Gary Hudes // Medical Oncology;Jun2009, Vol. 26 Issue 2, p202 

    Abstract   Purpose Exploratory subgroup analyses from the phase 3 global advanced renal cell carcinoma (ARCC) trial were conducted to assess the influence of tumor histology on outcome of patients treated with temsirolimus (Torisel™) or interferon-α (IFN). Patients and methods...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics